✦ LIBER ✦

A Phase I/II study of weekly paclitaxel and 3 days of high dose oral estramustine in patients with hormone-refractory prostate carcinoma

✍ Scribed by Anna C. Ferrari; Abraham Chachoua; Harvinder Singh; Mark Rosenthal; Samir Taneja; Myron Bednar; John Mandeli; Franco Muggia

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 82 KB
Volume: 91
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(20010601)91:11<2039::aid-cncr1230>3.0.co;2-r

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral estramustine and cyclophosphamide i

Oral estramustine and cyclophosphamide in patients with metastatic hormone refractory prostate carcinoma : A phase II study

✍ Sergio Bracarda; Maurizio Tonato; Paolo Rosi; Verena De Angelis; Ettore Mearini; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

## BACKGROUND. Nearly all cases of metastatic prostate carcinoma progress, after hormonal ablation, to a hormone refractory status. To the authors' knowledge no standard chemotherapy for patients with hormone refractory prostate carcinoma (HRPC) exists. In a prospective study, the efficacy and toxi

Phase II study of the oral cyclophospham

Phase II study of the oral cyclophosphamide and oral etoposide combination in hormone-refractory prostate carcinoma patients

✍ Catherine Maulard-Durdux; Bertrand Dufour; Christophe Hennequin; Y. Chrétien; Sy 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB 👁 2 views

## BACKGROUND. Hormonotherapy temporarily controls symptoms in 80% of patients with metastatic prostate carcinoma. Once progression occurs, no consensus exists on further therapy. Oral etoposide (vp-16) has shown clinical efficacy in advanced small cell lung carcinoma, breast cancer, germ cell tum

Fixed higher dose schedule of suramin pl

Fixed higher dose schedule of suramin plus hydrocortisone in patients with hormone refractory prostate carcinoma : A multicenter Phase II study

✍ Emiliano Calvo; Javier Cortés; Javier Rodríguez; Manuel Sureda; César Beltrán; J 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 1 views

A Phase II study of high-dose paclitaxel

A Phase II study of high-dose paclitaxel in patients with advanced neuroendocrine tumors

✍ Stephen M. Ansell; Henry C. Pitot; Patrick A. Burch; Larry K. Kvols; Michelle R. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

Phase II study of paclitaxel in patients

Phase II study of paclitaxel in patients with metastatic breast carcinoma refractory to standard chemotherapy

✍ Edgardo Rivera; Frankie A. Holmes; Debra Frye; Vicente Valero; Richard L. Theria 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

Chemotherapy in patients with prostate s

Chemotherapy in patients with prostate specific antigen–only disease after primary therapy for prostate carcinoma : A Phase II trial of oral estramustine and oral etoposide

✍ Hidayatullah G. Munshi; Kenneth J. Pienta; David C. Smith 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 1 views

## BACKGROUND. A Phase II study was initiated to evaluate the effectiveness of an oral regimen of etoposide and estramustine in patients with early recurrent prostate carcinoma. ## METHODS. Patients with early recurrent prostate carcinoma as indicated by an increasing prostate specific antigen